Nevertheless, H4K20me1 is critical in the maintenance of genome integrity [8] and its decrease upon UNC-0379 treatment would most likely contribute to the cytotoxic effects of this SETD8 inhibitor in myeloma cells. The gene discussed is KMT5A; the disease is plasma cell myeloma.